Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Novavax is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative vaccines. Utilizing proprietary protein nanoparticle technology, Novavax creates crucial immunizations against severe infectious diseases, including influenza and COVID-19, thereby contributing to global health.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Novavax is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Novavax last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.32 USD.
Across its last 3 earnings reports, Novavax stock moved by ±11.4% on average the following day. The largest reaction was +17.4% on 02/26/2026; 2 of 3 reactions were positive.
Novavax has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.